BB Biotech, Adamant Ventures and Adamant Biomedical Investments

  • $1bn healthcare AUM with a strong investment track record across Europe/Asia
  • BB Biotech Jan 1998 – Dec 2000 +306%
  • All additional funds outperformed Life Science/Biotech Index
    • SwissLife Funds Equity Biomedical 2001-2008, (Lipper 3 year best performance)
    • Lacuna Apo Biotech Fund 2003-2008
    • Oyster Oncology Fund 2006-2007
    • ABN Amro Healthcare Index 2007
    • Lacuna Asia Pacific Health Fund 2006-2007

Please note: Past performance is not a guarantee for future returns.